I saw a couple of months ago where there were 3 promising alzheimers drugs in the pipeline. If this is one of those, it is either the 2nd or 3rd one to fail since that came out. Does anyone know the details of this?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.